Fiji Declared Free from Trachoma by WHO, Marking a Milestone in Public Health

On October 20, 2025, the World Health Organization (WHO) officially validated Fiji's elimination of trachoma as a public health problem, marking a significant milestone in the nation's healthcare history. This achievement positions Fiji as the 26th country globally to eliminate trachoma and the 58th to eliminate at least one neglected tropical disease (NTD).

Trachoma, caused by the bacterium Chlamydia trachomatis, is the world's leading infectious cause of blindness. The disease spreads through personal contact, contaminated surfaces, and flies that have been in contact with the eye or nose discharge of an infected person. Repeated infections can lead to scarring, in-turning of the eyelids, and ultimately, blindness. Globally, trachoma remains endemic in many vulnerable communities where access to clean water and sanitation is limited.

Historically, trachoma was a significant health issue in Fiji. Medical reports from the 1930s and community-based surveys in the 1950s documented widespread disease and risk of blindness. By the 1980s, the condition had declined markedly, with cataract and refractive error emerging as the main causes of vision loss. However, in the 2000s, rapid assessments suggested high levels of active trachoma in children, prompting renewed concern and action.

In response to the resurgence, Fiji's Ministry of Health and Medical Services launched a comprehensive program to address trachoma. Since 2012, the country has undertaken a series of robust, internationally supported surveys and studies, including population-based prevalence surveys and laboratory testing, to understand the local epidemiology of trachoma and distinguish it from other causes of eye disease. This sustained effort, integrated with school health, water and sanitation initiatives, and community awareness programs, has confirmed that trachoma is no longer a public health problem in Fiji and that systems are in place to identify and manage future cases.

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, congratulated Fiji and its network of global and local partners on reaching this milestone. He stated, "Future generations of Fijians have been given a precious gift in being set free from the suffering that trachoma has inflicted on their ancestors."

Dr. Saia Ma’u Piukala, WHO Regional Director for the Western Pacific, highlighted the collaborative effort behind this success. He remarked, "Fiji’s success in eliminating trachoma is a beacon of what’s possible when communities, governments, and partners unite behind a shared goal. This is a celebration of the power of Pacific leadership and the impact of sustained investment in health."

Hon. Dr. Ratu Atonio Rabici Lalabalavu, Minister of Health and Medical Services of Fiji, emphasized the significance of this achievement for health equity in the Pacific. He noted, "Fiji’s elimination of trachoma is a defining moment for health equity in the Pacific. This achievement reflects years of coordinated action – across villages, health facilities, and regional platforms – demonstrating the unwavering commitment of our health-care workers and communities leading the change."

Neglected tropical diseases (NTDs) are a diverse group of diseases and conditions associated with devastating health, social, and economic consequences. They are mainly prevalent among impoverished communities in tropical areas. WHO estimates that NTDs affect more than 1 billion people. The targets included in the Road map for neglected tropical diseases 2021–2030 cover the prevention, control, elimination, and eradication of 20 diseases and disease groups by 2030.

Since 2016, 13 Member States in the Western Pacific Region, which covers 38 countries and areas, have been validated by WHO for eliminating at least one NTD. Of these, six (Cambodia, China, the Lao People’s Democratic Republic, Papua New Guinea, Vanuatu, and Viet Nam) have successfully eliminated trachoma as a public health problem. Trachoma elimination is part of broader progress on NTDs in Fiji and the rest of the Western Pacific Region.

The elimination of trachoma in Fiji has profound social and societal implications. This achievement signifies a major step toward health equity in the Pacific, ensuring that all individuals, regardless of their socio-economic status, have access to essential health services. By eliminating a leading cause of preventable blindness, Fiji can expect a reduction in healthcare costs associated with treating trachoma-related complications and an increase in productivity as more individuals maintain their sight and continue contributing to the economy. The success reflects the empowerment of communities through education and participation in health initiatives, fostering a sense of ownership and responsibility for public health.

Fiji's elimination of trachoma as a public health problem is a testament to the power of coordinated public health strategies, community engagement, and sustained investment in health. This milestone not only improves the quality of life for Fijians but also serves as an inspiring example for other nations striving to eliminate neglected tropical diseases.